Background: Postpartum hemorrhage is one of the most common obstetrical complications affecting up to 18% of deliveries. Globally, it is responsible for 35 – 55% of peripartum maternal deaths. In Cameroon, the maternal mortality rate is at 406 maternal death per 100,000 live births, with PPH being the leading cause accounting for about 25%. This study aimed to compare the efficacy and safety of misoprostol versus oxytocin in the prevention of postpartum hemorrhage in the Bamenda Health District and Nkwen Health District. Methods: This was a hospital-based randomized clinical trial study in the Bamenda Regional Hospital and Nkwen District Hospital. The study was conducted from March 1st to May 31st 2021 including pregnant women who delivered at the maternity at these two hospitals. All their pregnancy was singleton gestation at term and haven given their informed consent. Women with known history of cardiac, renal, hepatic diseases or any coagulopathy, Cesarean delivery were excluded. We randomized 308 participants in a 1:1 ratio to receive 800 μg of oral misoprostol or 10IU of oxytocin intramuscularly during the active management of third stage of labor (AMSTL). The Hemoglobin (Hb) concentration and hematocrit (HCT) of the participants were measured before and 24hrs after delivery. Our primary outcome of interest was (Post-Partum Hemorrhage) PPH, defined as Hb change ≥ 1g/dl within 24hrs of delivery. Secondary outcomes included; mean Hb change, Hb change ≥2g/dl (severe PPH). Dichotomous outcomes between study groups were compared by estimating crude relative risks (RRs) with 95% confidence intervals. Logistic regression (the chi-square test) was done to determine the factors associated with the occurrence of postpartum hemorrhage, with a level of significance at 5%. Results: After 24hrs, Postpartum hemorrhage (PPH) occurred in 41 (26.6%) and 47 (30.5%) participants in the misoprostol and oxytocin groups respectively (RR= 0.87, 95% C.I= 0.61 - 1.24, p=0.449). Severe postpartum hemorrhage occurred in 3 (1.9%) and 5 (3.2%) participants in the misoprostol and oxytocin groups respectively (RR= 0.6, 95% C.I=0.15 - 2.47, p=0.723). Past history of PPH (aOR=10.1 (3.5 – 28.6), p<0.0001), augmentation of labor (aOR=3.4 (1.6 – 7.1), p=0.0011), fetal birth weight ≥3.5Kg (aOR=2.5 (1.3 – 4.8), p=0.0074) and retained products (aOR= 8.4 (4.2 – 16.7), p<0.0001) were risk factors of PPH. Participants in the misoprostol group more commonly experienced shivering (RR 3.2, 95% CI 2.0 - 5.1, p<0.0001) and nausea/vomiting (RR 35.5, 95% CI 8.9 – 142.2, p<0.0001). Conclusion: Oral misoprostol at the dose of 800μg is as effective as 10 IU IM Oxytocin in the prevention of PPH and is a potent alternative to oxytocin. Most common risk factors of PPH are past history of PPH, augmentation of labor, fetal weight ≥ 3.5kg and retained products. Side effects were mostly associated with 800μg of oral Misoprostol.
{"title":"Prevention of Post-Partum Hemorrhage: Comparison of Oxytocin and Misoprostol. A Two center study in the Bamenda and Nkwen Health Districts","authors":"Takang Wa, Ndundat Av, Dohbit Js, Ngo Teke G, Ndundat Ac, Guifo S, Mbakwa Rm","doi":"10.33425/2833-034x.1009","DOIUrl":"https://doi.org/10.33425/2833-034x.1009","url":null,"abstract":"Background: Postpartum hemorrhage is one of the most common obstetrical complications affecting up to 18% of deliveries. Globally, it is responsible for 35 – 55% of peripartum maternal deaths. In Cameroon, the maternal mortality rate is at 406 maternal death per 100,000 live births, with PPH being the leading cause accounting for about 25%. This study aimed to compare the efficacy and safety of misoprostol versus oxytocin in the prevention of postpartum hemorrhage in the Bamenda Health District and Nkwen Health District. Methods: This was a hospital-based randomized clinical trial study in the Bamenda Regional Hospital and Nkwen District Hospital. The study was conducted from March 1st to May 31st 2021 including pregnant women who delivered at the maternity at these two hospitals. All their pregnancy was singleton gestation at term and haven given their informed consent. Women with known history of cardiac, renal, hepatic diseases or any coagulopathy, Cesarean delivery were excluded. We randomized 308 participants in a 1:1 ratio to receive 800 μg of oral misoprostol or 10IU of oxytocin intramuscularly during the active management of third stage of labor (AMSTL). The Hemoglobin (Hb) concentration and hematocrit (HCT) of the participants were measured before and 24hrs after delivery. Our primary outcome of interest was (Post-Partum Hemorrhage) PPH, defined as Hb change ≥ 1g/dl within 24hrs of delivery. Secondary outcomes included; mean Hb change, Hb change ≥2g/dl (severe PPH). Dichotomous outcomes between study groups were compared by estimating crude relative risks (RRs) with 95% confidence intervals. Logistic regression (the chi-square test) was done to determine the factors associated with the occurrence of postpartum hemorrhage, with a level of significance at 5%. Results: After 24hrs, Postpartum hemorrhage (PPH) occurred in 41 (26.6%) and 47 (30.5%) participants in the misoprostol and oxytocin groups respectively (RR= 0.87, 95% C.I= 0.61 - 1.24, p=0.449). Severe postpartum hemorrhage occurred in 3 (1.9%) and 5 (3.2%) participants in the misoprostol and oxytocin groups respectively (RR= 0.6, 95% C.I=0.15 - 2.47, p=0.723). Past history of PPH (aOR=10.1 (3.5 – 28.6), p<0.0001), augmentation of labor (aOR=3.4 (1.6 – 7.1), p=0.0011), fetal birth weight ≥3.5Kg (aOR=2.5 (1.3 – 4.8), p=0.0074) and retained products (aOR= 8.4 (4.2 – 16.7), p<0.0001) were risk factors of PPH. Participants in the misoprostol group more commonly experienced shivering (RR 3.2, 95% CI 2.0 - 5.1, p<0.0001) and nausea/vomiting (RR 35.5, 95% CI 8.9 – 142.2, p<0.0001). Conclusion: Oral misoprostol at the dose of 800μg is as effective as 10 IU IM Oxytocin in the prevention of PPH and is a potent alternative to oxytocin. Most common risk factors of PPH are past history of PPH, augmentation of labor, fetal weight ≥ 3.5kg and retained products. Side effects were mostly associated with 800μg of oral Misoprostol.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139366606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To report successful in vivo fertilization in four out of five women with diminished ovarian reserve (DOR) after transuterine perfusion of the ovaries and pelvis with autologous platelet-rich plasma (PRP). Methods: Patients that exhibited DOR (defined as AMH <1.1 ng/mL and antral follicular count of < 7 follicles) and had failed in vitro fertilization and/or artificial insemination in the past year were offered transuterine perfusion of PRP with oral letrozole and timed intercourse as an alternative therapy. Five patients accepted the protocol. Patients took 10 mg of letrozole orally from day 3 to day 7 of the menstrual cycle to increase chances of ovulation. They underwent one transuterine perfusion of the pelvis during the follicular phase of each cycle with a 10 mL volume of fresh autologous platelet-rich plasma under ultrasound guidance to allow periovarian spillage from the fallopian tubes. Result: In 4 out of 5 cases patients conceived without the need for in vitro intervention. Three patients had a successful pregnancy. One patient had a miscarriage at 19 weeks. One patient did not conceive within the four months of observation. Conclusion: Delivering platelet-rich plasma to the ovaries by transuterine perfusion may be a safe and cost-effective approach to enhance fertility in women with impaired ovarian reserve undergoing fertility therapies.
{"title":"Transuterine Perfusion of Platelet-Rich Plasma in Infertile Women with Diminished Ovarian Reserve: A Case Series with In Vivo Conception and Continuing Pregnancies","authors":"M. Verdiales","doi":"10.33425/2833-034x.1008","DOIUrl":"https://doi.org/10.33425/2833-034x.1008","url":null,"abstract":"Purpose: To report successful in vivo fertilization in four out of five women with diminished ovarian reserve (DOR) after transuterine perfusion of the ovaries and pelvis with autologous platelet-rich plasma (PRP). Methods: Patients that exhibited DOR (defined as AMH <1.1 ng/mL and antral follicular count of < 7 follicles) and had failed in vitro fertilization and/or artificial insemination in the past year were offered transuterine perfusion of PRP with oral letrozole and timed intercourse as an alternative therapy. Five patients accepted the protocol. Patients took 10 mg of letrozole orally from day 3 to day 7 of the menstrual cycle to increase chances of ovulation. They underwent one transuterine perfusion of the pelvis during the follicular phase of each cycle with a 10 mL volume of fresh autologous platelet-rich plasma under ultrasound guidance to allow periovarian spillage from the fallopian tubes. Result: In 4 out of 5 cases patients conceived without the need for in vitro intervention. Three patients had a successful pregnancy. One patient had a miscarriage at 19 weeks. One patient did not conceive within the four months of observation. Conclusion: Delivering platelet-rich plasma to the ovaries by transuterine perfusion may be a safe and cost-effective approach to enhance fertility in women with impaired ovarian reserve undergoing fertility therapies.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139366551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Proper breastfeeding and complementary feeding at the beginning of birth until the age of 24 months has an important role in optimizing nutrition for the first 1000 days of life to obtain optimal individual health status until adulthood. Objectives: This study aims to analyze the impact of antenatal care (ANC) and postnatal care (PNC), especially nutritional counseling on the success of exclusive breastfeeding and appropriate complementary foods. Methods: This study used a cross-sectional design from secondary data from basic health research (RISKESDAS) in DKI Jakarta Province with a total sample of 230 mothers aged 15-49 years who had children aged 6-24 months. Data were analyzed univariate, bivariate using the Chi-Square test and multivariate using multiple logistic regression tests. Results: The results showed that the coverage of exclusive breastfeeding was 56.5% and proper complementary food was 39.6%. The results of the Chi Square test showed that there was a relationship between exclusive breastfeeding and maternal age (p = 0.025) (OR: 2.21 95% CI: 1.09 – 4.48), maternal education (p = 0.008) (OR: 4.80 95% CI: 1.79 – 12.8) , maternal parity (p = 0.009) (OR: 2.58 95% CI: 1.25 – 5.30), antenatal care (p = 0.000) (OR: 4.82 95% CI: 2.13 – 10.9), and postnatal counseling (p = 0.006) (OR: 2.72 95% CI: 1.31 – 5.65). Meanwhile, on the accuracy of complementary feeding, there was a relationship between maternal age (p = 0.027) (OR 2.32 95% CI 1.07-5.02), maternal education (p = 0.000) (OR 3.16 95% CI 1.67-5.98), maternal parity (p = 0.027) (OR 2.36 95% CI 1.08- 5.17), received ANC (p = 0.000) (OR 4.61 95% CI 1.84-11.6), and nutrition counseling (p = 0.004) (OR 2.98 95% CI 1.38-6.43). The most dominant variable with the success of exclusive breastfeeding and complementary feeding for the first time is ANC with odds ratios of 4.82 and 4.08, respectively, after being controlled by postnatal counseling. Conclusion: This study shows that the impact of ANC and PNC, especially nutritional counseling, has a role in the success of exclusive breastfeeding and the appropriateness of giving complementary foods for the first time. ANC and PNC, especially nutrition counseling, are very important for every pregnant woman and need to be socialized to relevant policy makers and pregnant women's families.
{"title":"The Impact of Antenatal Care and Nutrition Counseling on the Success of Exclusive Breastfeeding and Appropriate First Complementary Foods","authors":"Dhamas Pratista, Trina Astuti, Mochamad Rachmat","doi":"10.33425/2833-034x.1010","DOIUrl":"https://doi.org/10.33425/2833-034x.1010","url":null,"abstract":"Background: Proper breastfeeding and complementary feeding at the beginning of birth until the age of 24 months has an important role in optimizing nutrition for the first 1000 days of life to obtain optimal individual health status until adulthood. Objectives: This study aims to analyze the impact of antenatal care (ANC) and postnatal care (PNC), especially nutritional counseling on the success of exclusive breastfeeding and appropriate complementary foods. Methods: This study used a cross-sectional design from secondary data from basic health research (RISKESDAS) in DKI Jakarta Province with a total sample of 230 mothers aged 15-49 years who had children aged 6-24 months. Data were analyzed univariate, bivariate using the Chi-Square test and multivariate using multiple logistic regression tests. Results: The results showed that the coverage of exclusive breastfeeding was 56.5% and proper complementary food was 39.6%. The results of the Chi Square test showed that there was a relationship between exclusive breastfeeding and maternal age (p = 0.025) (OR: 2.21 95% CI: 1.09 – 4.48), maternal education (p = 0.008) (OR: 4.80 95% CI: 1.79 – 12.8) , maternal parity (p = 0.009) (OR: 2.58 95% CI: 1.25 – 5.30), antenatal care (p = 0.000) (OR: 4.82 95% CI: 2.13 – 10.9), and postnatal counseling (p = 0.006) (OR: 2.72 95% CI: 1.31 – 5.65). Meanwhile, on the accuracy of complementary feeding, there was a relationship between maternal age (p = 0.027) (OR 2.32 95% CI 1.07-5.02), maternal education (p = 0.000) (OR 3.16 95% CI 1.67-5.98), maternal parity (p = 0.027) (OR 2.36 95% CI 1.08- 5.17), received ANC (p = 0.000) (OR 4.61 95% CI 1.84-11.6), and nutrition counseling (p = 0.004) (OR 2.98 95% CI 1.38-6.43). The most dominant variable with the success of exclusive breastfeeding and complementary feeding for the first time is ANC with odds ratios of 4.82 and 4.08, respectively, after being controlled by postnatal counseling. Conclusion: This study shows that the impact of ANC and PNC, especially nutritional counseling, has a role in the success of exclusive breastfeeding and the appropriateness of giving complementary foods for the first time. ANC and PNC, especially nutrition counseling, are very important for every pregnant woman and need to be socialized to relevant policy makers and pregnant women's families.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139367181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Graves’ disease, a well-known cause of hyperthyroidism, is an autoimmune disease with multi-system involvement. More prevalent among young women, it appears as an uncommon cardiovascular complication during pregnancy, posing a diagnostic challenge, largely owing to difficulty in detecting the complication, because of a low index of suspicion of Graves’ disease presenting during pregnancy. Globally, cardiovascular disease is an important factor for pregnancy-related morbidity and mortality. Here, we report a case of 24 years old primi with Graves’ disease detected for the first time in pregnancy presenting with acute hypertensive left heart failure and severe pre-eclampsia. She was found to have abnormal thyroid function tests compatible with the diagnosis of Graves’ disease. Emphasis is placed on the spectrum of clinical presentations of Graves’ disease, and the importance of considering this thyroid disorder as a possible aetiological factor for such a presentation in pregnancy.
{"title":"A Case of 31 WKS Primi with Acute Hypertensive Left Heart Failure with Severe Pre- Eclampsia Secondary to Graves’ Disease","authors":"R. Gomes","doi":"10.33425/2833-034x.1002","DOIUrl":"https://doi.org/10.33425/2833-034x.1002","url":null,"abstract":"Graves’ disease, a well-known cause of hyperthyroidism, is an autoimmune disease with multi-system involvement. More prevalent among young women, it appears as an uncommon cardiovascular complication during pregnancy, posing a diagnostic challenge, largely owing to difficulty in detecting the complication, because of a low index of suspicion of Graves’ disease presenting during pregnancy. Globally, cardiovascular disease is an important factor for pregnancy-related morbidity and mortality. Here, we report a case of 24 years old primi with Graves’ disease detected for the first time in pregnancy presenting with acute hypertensive left heart failure and severe pre-eclampsia. She was found to have abnormal thyroid function tests compatible with the diagnosis of Graves’ disease. Emphasis is placed on the spectrum of clinical presentations of Graves’ disease, and the importance of considering this thyroid disorder as a possible aetiological factor for such a presentation in pregnancy.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121777064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohameth Mbodj, N. Seck, S. T. Ndiaye, K. Bop, Papa Souleye Sow, I. Diagne
Herpes zoster in children is rare and particularly the ophthalmic form, which can be responsible for serious ocular complications. We report the case of a 6-year-old female patient with herpes zoster ophthalmicus. The patient was 6 years old and hospitalised with a painful rash. The examination revealed an infectious syndrome, a painful vesicular rash, in a cluster, resting on an erythematous background located on the forehead and the root of the nose with eyelid edema. Slit lamp examination came back normal. The diagnosis of herpes zoster ophthalmicus was made on the basis of clinical findings. The course was favourable on acyclovir with no ocular complications and no post-herpetic pain.
{"title":"Ophthalmic Zoster, A Rare Pathology in a Child","authors":"Mohameth Mbodj, N. Seck, S. T. Ndiaye, K. Bop, Papa Souleye Sow, I. Diagne","doi":"10.33425/2833-034x.1003","DOIUrl":"https://doi.org/10.33425/2833-034x.1003","url":null,"abstract":"Herpes zoster in children is rare and particularly the ophthalmic form, which can be responsible for serious ocular complications. We report the case of a 6-year-old female patient with herpes zoster ophthalmicus. The patient was 6 years old and hospitalised with a painful rash. The examination revealed an infectious syndrome, a painful vesicular rash, in a cluster, resting on an erythematous background located on the forehead and the root of the nose with eyelid edema. Slit lamp examination came back normal. The diagnosis of herpes zoster ophthalmicus was made on the basis of clinical findings. The course was favourable on acyclovir with no ocular complications and no post-herpetic pain.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126045456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Dysmenorrhea is a disease, which occurs in about 45% of women in childbearing age. Objective: Dose finding study to evaluate the activity of specific physiological modulators (PMs) aimed at protecting GABAA receptors and CaSRs (calcium sensing receptors) against oxidative stress (OS) and at reducing the discomfort caused by dysmenorrhea. Methods: The discomfort was measured using a score of from 0 to 5 and plasma antioxidant capacity was determined using a plasma antioxidant test (PAT). The PMs were combined and administered at low doses in the form of specific foods (SFs) and capsules. Twenty women with a score of ≥ 3 took part in the study during 5 sessions of 4 hours. In session 1, the women were treated with placebo, whereas in sessions from 2 to 5 they alternated between capsules and SFs containing the same amount of PMs. In sessions 4 and 5, the PM doses were double those taken in sessions 2 and 3. At the end of each sessions, women were asked about the need of pain relief as an indirect measurement of treatment efficacy. Results: The SFs and capsules reduced the discomfort in 60% and 75% of cases respectively. However, the effect with capsules was more rapid and lasted longer than with SFs. The need for pain relief was lower after treatment with capsules than it was with SFs. The increase in PAT was similar for both treatments. Conclusions: PMs taken as SFs or capsules showed similar activity, but capsules had a significantly more rapid and longer lasting effect.
{"title":"Dysmenorrhea Clinical Pharmacology: Dose Finding of Physiological Modulators in Foods or Capsules","authors":"C. U","doi":"10.33425/2833-034x.1004","DOIUrl":"https://doi.org/10.33425/2833-034x.1004","url":null,"abstract":"Background: Dysmenorrhea is a disease, which occurs in about 45% of women in childbearing age. Objective: Dose finding study to evaluate the activity of specific physiological modulators (PMs) aimed at protecting GABAA receptors and CaSRs (calcium sensing receptors) against oxidative stress (OS) and at reducing the discomfort caused by dysmenorrhea. Methods: The discomfort was measured using a score of from 0 to 5 and plasma antioxidant capacity was determined using a plasma antioxidant test (PAT). The PMs were combined and administered at low doses in the form of specific foods (SFs) and capsules. Twenty women with a score of ≥ 3 took part in the study during 5 sessions of 4 hours. In session 1, the women were treated with placebo, whereas in sessions from 2 to 5 they alternated between capsules and SFs containing the same amount of PMs. In sessions 4 and 5, the PM doses were double those taken in sessions 2 and 3. At the end of each sessions, women were asked about the need of pain relief as an indirect measurement of treatment efficacy. Results: The SFs and capsules reduced the discomfort in 60% and 75% of cases respectively. However, the effect with capsules was more rapid and lasted longer than with SFs. The need for pain relief was lower after treatment with capsules than it was with SFs. The increase in PAT was similar for both treatments. Conclusions: PMs taken as SFs or capsules showed similar activity, but capsules had a significantly more rapid and longer lasting effect.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115387611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Haji, Elieza Chibwe, Fridolin Mujuni, Namanya Basinda, M. Mirambo, P. Ngoya, Richard Kirrita, A. Kihunrwa, D. Matovelo
Uterine torsion is considered rare conditions in human as compared to veterinary medicine. Despite being less commonly reported, it is associated with morbidities and mortalities to both fetal and maternal. When the rotation of the uterus is more than 45 degrees on its longitudinal axis is considered pathological. We report a 26-year-old woman, prime gravid, at Gestational age of 40 weeks who stayed in labor for 8hours with 6 centimeters cervical dilatation despite of adequate uterine contractions. She was delivered by caesarean section due to intrapartum fetal surveillance found to be bradycardic (fetal heart tones ranging from 108 to 110 beats per minutes) regardless of maternal changing position. A live baby boy with Apgar score of six at first and eight at firth minutes respectively birth weight 3.7 kilograms was delivered and Intraoperatively, uterine torsion of 180 degrees was diagnosed. We present this case as the rare diagnosis which is associated with significant morbidity and mortality of both maternal and neonates.
{"title":"Uterine Torsion Diagnosed During Cesarean Section in a 26-Year-Old Female at Bugando Medical Centre, A Case Report","authors":"A. Haji, Elieza Chibwe, Fridolin Mujuni, Namanya Basinda, M. Mirambo, P. Ngoya, Richard Kirrita, A. Kihunrwa, D. Matovelo","doi":"10.33425/2833-034x.1001","DOIUrl":"https://doi.org/10.33425/2833-034x.1001","url":null,"abstract":"Uterine torsion is considered rare conditions in human as compared to veterinary medicine. Despite being less commonly reported, it is associated with morbidities and mortalities to both fetal and maternal. When the rotation of the uterus is more than 45 degrees on its longitudinal axis is considered pathological. We report a 26-year-old woman, prime gravid, at Gestational age of 40 weeks who stayed in labor for 8hours with 6 centimeters cervical dilatation despite of adequate uterine contractions. She was delivered by caesarean section due to intrapartum fetal surveillance found to be bradycardic (fetal heart tones ranging from 108 to 110 beats per minutes) regardless of maternal changing position. A live baby boy with Apgar score of six at first and eight at firth minutes respectively birth weight 3.7 kilograms was delivered and Intraoperatively, uterine torsion of 180 degrees was diagnosed. We present this case as the rare diagnosis which is associated with significant morbidity and mortality of both maternal and neonates.","PeriodicalId":405846,"journal":{"name":"Womens Health Care and Issues","volume":"2015 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127690242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：